Showing posts with label UTI. Show all posts
Showing posts with label UTI. Show all posts

Wednesday, April 18, 2018

A novel, single-use Foley’s catheter fixation device protects from accidental removal and trauma



Indwelling urinary catheters are very commonly used for inpatients in hospitals and people confined to bed in hospice and nursing homes. It is estimated that 25% of hospitalized patients have catheters placed during their hospital stay.

They are also associated with Urinary Tract Infections (UTI) and account for 70-80% of iatrogenic UTI in hospital and inpatient settings. But, genitourinary trauma is also common because of the inflated balloon during accidental pulling of Foley’s catheter.

Foleysafe by Cathetrix is a single use, catheter fixation device that is attached to the catheter. Upon pulling of the inflated catheter a cutting mechanism is immediately activated which severs the catheter, causing the retention balloon to deflate and thus preventing any trauma to the patient. It works well with both latex and silicone Foley’s catheter.



The product has gained CE and FDA type 1 clearance and is currently in the production phase. It is the debut product of Cathetrix, an innovative catheter securement devices company, developing and producing smart catheter fixations. It has joined with 3BY ltd for the production of Foleysafe.





Sunday, January 28, 2018

UTI in pregnancy: nitrofurantoin and trimethoprim-sulfamethoxazole overprescribed despite potential risks.


Nitrofurantoin and trimethoprim-sulfamethoxazole were commonly prescribed for pregnant women during first trimester in 2014, despite the potential risk associated with these antibiotics, reports the results of analysis of large insurance database by Center for Disease Control(CDC). These findings were reported in the Morbidity and Mortality Weekly Report(MMWR) by CDC issued January 12, 2018.

Pregnant women are routinely screened for UTI in pregnancy and receive antibiotics if they screen positive, because of foreseen serious complication later in pregnancy like pyelonephritis, preterm labor, low birth weight, and sepsis.

ACOG recommends to being selective in prescribing antibiotics during first trimester because of potential of birth defects with certain antibiotics. ACOG recommends that nitrofurantoin and trimethoprim-sulfamethoxazole should only be prescribed in early pregnancy when other antibiotics are found ineffective.

CDC gathered data of about 482,917 pregnancies from Truven Health MarketScan Commercial Database and analyzed it for prescription filled for antibiotics during the first trimester.

All pregnant women between aged 15–44 years with a diagnosis of a UTI from 90 days before LMP through the end of pregnancy were identified to be included in the study. UTI was defined according to the International Classification of Diseases Ninth Revision, Clinical Modification (ICD-9 CM) diagnosis code or presence of cystitis with an outpatient prescription filled.

Women with recurrent UTI or those who were admitted were excluded from study.

The data showed that 34,864 (7.2%) pregnant women had an initial outpatient UTI claim 90 days before or during pregnancy.  UTI was most common during the first trimester (40%) and least common in the third trimester of pregnancy.

Types of antibiotics prescribed differed according to pregnancy status of women, with fluoroquinolones and sulfonamides more commonly prescribed to women within 90 days before their LMP while nitrofurantoin, cephalosporins and penicillins were the drugs of choice during pregnancy.

The most common antibiotics prescribed during the first trimester were nitrofurantoin (34.7%), ciprofloxacin (10.5%), cephalexin (10.3%), and trimethoprim-sulfamethoxazole (7.6%).

This report has its own limitations because UTI was identified only based on codes and not lab reports, some women may have other concomitant infections for which these antibiotics were prescribed, the MarketScan sample was a convenient sample hence could not be generalized to whole of US populations and out of pocket payee women were not included in the study.

Inspite of these limitations,  the report shows that it is important for all healthcare providers to be aware of antibiotic recommendations in pregnancy and be aware that they are prescribing for two in women who are pregnant or who might get pregnant in coming months.   





Wednesday, April 26, 2017

Autonomous sensors to detect UTI at early stage developed at Purdue.

courtesy: http://www.damngeeky.com/


Urinary Tract Infection now can be diagnosed at early stage with an autonomous sensor developed by researchers at Purdue University.

“Current testing relies on time-consuming and costly urine culture tests performed at medical facilities and on at-home testing using store-purchased dipsticks that generally have high false alarm rates,” says Babak Ziaie, professor of electrical and computer engineering in Purdue’s School of Electrical and Computer Engineering. “Additionally, collecting urine samples for these methods can be challenging for infants and geriatric patients who suffer from neurodegenerative diseases. There’s also a privacy and dignity issue.”

UTI are common at extremes of age and is associated with significant morbidity and long-term medical consequences. In fact, they are most common infections in older adults specially in institutional settings. A woman’s lifetime risk for being diagnosed with UTI is more than 50%.

The researchers have developed bandage size disposable sensor, that is operated by battery which is activated after coming in contact with urine. The sensors detect nitrites, the chemical compound formed in UTI, and wirelessly sends the result to a smartphone app that keeps the data log and sends the results to the patient, caregiver, and/or health-care network if required.

The sensor can be easily embedded in the diaper.

“Ours is the only one that works fully autonomously,” Ziaie said. “Conventional methods require a certain level of patient or caregiver intervention.” This will be especially useful in infants and older adults who are not aware of symptoms or who do not have the ability to report the symptoms.

Work is now shifting to sizing, packaging, diaper embedding methods, smartphone app details and other efforts to prepare the technology for commercialization. A pilot study also is planned.

Several patents are already pending on this prototype but, this is the only one which is autonomous.  
“Once you detect a urinary tract infection in its early stage, it’s very easy to cure,” said team member Byunghoo Jung, associate professor of electrical and computer engineering in the School of Electrical and Computer Engineering. “You just need an antibiotic. Early detection is the key.”